8-K
Current Report
Compass Therapeutics, Inc. Filed Acc 0001193125-21-182106
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d175899d8k.htm…